About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
AGM Chairman and CEO Addresses
May 31, 2017
Click here to read more
Post navigation
Previous Post
Mylan Arbitration Update – expert report on quantum of damages claimed filed
Next Post
2017 AGM Resuls
Related Posts
CBD soft-gel product design complete
May 21, 2021
May 21, 2021
Phosphagenics Announces Results of TPM Oxycodone Phase 2a Trial
January 29, 2016
Phosphagenics Mylan Arbitration Hearing Concluded
November 9, 2017